Literature DB >> 16553359

Cholesteryl ester transfer protein gene polymorphisms and severity of coronary stenosis.

Genovefa D Kolovou1, Katherine K Anagnostopoulou, Panagiotis Karyofillis, Klelia D Salpea, Nikos Yiannakouris, Dimitris Zarkalis, Dennis V Cokkinos.   

Abstract

PURPOSE: Cholesteryl ester transfer protein (CETP) gene is involved in the reverse cholesterol transport in humans. Thus, it is a candidate for studying the susceptibility to coronary heart disease (CHD). The goal of the current investigation was to determine any association between CETP polymorphisms (I405V and TaqIB), and severity of coronary stenosis, since the extent of coronary artery narrowing has been considered as a primary determinant of survival in CHD patients.
METHODS: The severity of coronary stenosis was estimated by Gensini (GS) and Duke Jeopardy (JS) scores in 130 men with documented CHD (mean age 61 +/- 10 yr). Genotyping was performed by polymerase chain reaction and restriction fragment length polymorphism analysis.
RESULTS: The allele frequencies for both TaqIB and I405V were found in Hardy-Weinberg equilibrium. Homozygotes for I had lower GS compared with heterozygotes (IV) and homozygotes for V [72(95% CI 51-92) vs. 122(95% CI 88-157) and 136 (95% CI 74-198), P = 0.009, P = 0.010, respectively]. In addition, GS differed between carriers of I and carriers of V allele [86(95% CI 72-101) vs. 128(95% CI 102-154), P = 0.003]. A correlation was found between the GS and I405V polymorphism (r = 0.250, P = 0.005), but not with JS.
CONCLUSION: Homozygosity for I405 favours less severe coronary stenosis. Our findings indicate that the I405V polymorphism may have potential importance in screening individuals at high risk for developing CHD, establishing efficient prevention measures, and searching for other risk factors for CHD. However, further prospective investigations in larger populations are required to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16553359

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  5 in total

1.  TaqIB and severity of coronary artery disease in the Turkish population: a pilot study.

Authors:  Dilara Kaman; Necip İlhan; Nevin İlhan; Mehmet Akbulut
Journal:  Bosn J Basic Med Sci       Date:  2015-02-01       Impact factor: 3.363

2.  Cholesteryl ester transfer protein gene polymorphisms and longevity syndrome.

Authors:  Genovefa Kolovou; Marianna Stamatelatou; Katherine Anagnostopoulou; Peggy Kostakou; Vana Kolovou; Constantinos Mihas; Ioannis Vasiliadis; Olga Diakoumakou; Dimitri P Mikhailidis; Dennis V Cokkinos
Journal:  Open Cardiovasc Med J       Date:  2010-01-29

3.  The role of common variants of the cholesteryl ester transfer protein gene in left main coronary artery disease.

Authors:  Genovefa Kolovou; Ioannis Vasiliadis; Vana Kolovou; Agathi Karakosta; Sophie Mavrogeni; Evaggelia Papadopoulou; Spiridon Papamentzelopoulos; Vasiliki Giannakopoulou; Apostolia Marvaki; Dimitrios Degiannis; Helen Bilianou
Journal:  Lipids Health Dis       Date:  2011-09-07       Impact factor: 3.876

4.  Cholesteryl ester transfer protein gene and effectiveness of lipid lowering of atorvastatin.

Authors:  Genovefa Kolovou; Constantinos Mihas; Katherine Anagnostopoulou; Vana Kolovou; Vasiliki Giannakopoulou; Peggy Kostakou; Marianna Stamatelatou; Sophie Mavrogeni; Dimitrios Degiannis; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2010-12-10

5.  The link between human and transgenic animal studies involving postprandial hypertriglyceridemia and CETP gene polymorphisms.

Authors:  Genovefa D Kolovou; Katherine K Anagnostopoulou; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2009-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.